By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Envoy Therapeutics and Takeda Pharmaceutical have formed a three-year alliance to discover drug candidates for treating schizophrenia, the firms announced today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.